Well and intermediate differentiated laryngeal chondrosarcoma: toward conservative surgery?
- PMID: 23974330
- DOI: 10.1007/s00405-013-2656-0
Well and intermediate differentiated laryngeal chondrosarcoma: toward conservative surgery?
Abstract
Chondrosarcoma of the larynx is a relatively rare malignant tumor. In the world literature, only 600 cases of laryngeal chondrosarcoma (LCS) have been reported. It is the most frequent non-epithelial tumor of the larynx (0.07-2% of all cancers), usually occurring on the cricoid. We present six cases of well-intermediate differentiated grade chondrosarcoma of the larynx, diagnosed between the fifth and seventh decades of life, in the absence of relevant risk factors. All cases were subjected to a conservative surgical approach, either endoscopic using remodeling transoral laser surgery, or open neck via a supratracheal partial laryngectomy (STL), sparing laryngeal function. All patients are free from recurrence with a minimum follow-up of 31 months. All were ultimately decannulated, are able to tolerate a quite normal diet and to speak satisfactorily. Conservative laryngeal surgery is effective because chondrosarcoma is often a low-grade tumor showing slow growth. The criteria for choosing the type of surgery was based on the age of the patient (elderly patient > favoring an endoscopic approach), on the rate of involvement of the cricoid and on the involvement of the cricoarytenoid joints (if possible to save a cricoarytenoid unit > favoring a STL). By extending the inferior limit of the resection to include a large part of the cricoid cartilage, supratracheal partial laryngectomies expanded the indications to some LCSs not involving the entire cricoid lamina sparing laryngeal function and avoiding the need for total laryngectomy.
Similar articles
-
[Subtotal cricoid resection as primary therapy for a highly differentiated chondrosarcoma].HNO. 2007 Sep;55(9):719-22. doi: 10.1007/s00106-006-1427-2. HNO. 2007. PMID: 16770598 German.
-
Chondrosarcoma treated with transoral near total resection of the cricoid.B-ENT. 2014;10(2):121-5. B-ENT. 2014. PMID: 25090810
-
Organ preservation surgery for low- and intermediate-grade laryngeal chondrosarcomas: analysis of 16 cases.Laryngoscope. 2014 Apr;124(4):907-12. doi: 10.1002/lary.24416. Epub 2013 Oct 22. Laryngoscope. 2014. PMID: 24122809
-
Contemporary Surgical Approaches in Managing Laryngeal Chondrosarcoma: A Scoping Review.Laryngoscope. 2025 Jul;135(7):2241-2248. doi: 10.1002/lary.32068. Epub 2025 Feb 19. Laryngoscope. 2025. PMID: 39968575
-
Laryngeal chondrosarcoma: incidence, pathology, biological behavior, and treatment.Ann Otol Rhinol Laryngol. 1990 Jul;99(7 Pt 1):515-23. doi: 10.1177/000348949009900704. Ann Otol Rhinol Laryngol. 1990. PMID: 2195959 Review.
Cited by
-
Laryngeal chondrosarcoma, case report and literature review.Int J Surg Case Rep. 2018;51:62-66. doi: 10.1016/j.ijscr.2018.07.041. Epub 2018 Aug 9. Int J Surg Case Rep. 2018. PMID: 30144712 Free PMC article.
-
Recurrent chondrosarcoma of the larynx: A case report and literature review.Medicine (Baltimore). 2016 Jul;95(27):e4118. doi: 10.1097/MD.0000000000004118. Medicine (Baltimore). 2016. PMID: 27399118 Free PMC article. Review.
-
Treatment strategy in laryngeal chondrosarcoma: a multicenter study of 43 cases.Eur Arch Otorhinolaryngol. 2024 Feb;281(2):883-890. doi: 10.1007/s00405-023-08248-7. Epub 2023 Sep 27. Eur Arch Otorhinolaryngol. 2024. PMID: 37752251
-
Chondrosarcomas of the head and neck.Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2601-9. doi: 10.1007/s00405-013-2807-3. Epub 2013 Nov 10. Eur Arch Otorhinolaryngol. 2014. PMID: 24213203 Review.
-
Surgical management and oncological outcome of non-squamous cell carcinoma of the larynx: a bicentric study.Eur Arch Otorhinolaryngol. 2022 Jan;279(1):299-310. doi: 10.1007/s00405-021-07076-x. Epub 2021 Sep 24. Eur Arch Otorhinolaryngol. 2022. PMID: 34557960 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources